Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Classifying Health IT Still Key Focus For Digital Health Regulation

This article was originally published in The Gray Sheet

Executive Summary

Conceptual fuzziness still an issue with regulating health IT, observers agree.

You may also be interested in...



FDA Reiterates Intention To Regulate Only A Small Portion Of Mobile Medical Apps

On the last day of hearings by three House Energy and Commerce subcommittees March 19-21, CDRH Office of Device Evaluation Director Christy Foreman largely reiterated FDA’s previously stated approach to regulating mobile medical apps. Meanwhile, Energy and Commerce Committee Vice Chair Marsha Blackburn, R-Tenn., hinted at legislation on the issue

Government Agencies Form Work Group To Develop Health IT Framework

The group will assist mandatory efforts by FDA, the Federal Communications Commission and the Office of the National Coordinator for Health Information Technology to issue recommendations for a risk-based regulatory framework for health IT, including mobile medical apps.

FDA Outlines Path For Guidance On Clinical Decision Support Tools

CDRH officials are looking for ways to better define when and how clinical decision support tools included in mobile health applications or medical software should face FDA regulation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031936

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel